Belongs to

• Solid Tumor Oncology Division

Types of Work

["2019"]

[[["Meeting Abstracts",193],["Journal Articles",183],["Reviews",4],["Editorials",3],["Research Letters",3],["Book Sections",1]]]

[387]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• gene mutation
• human
• major clinical study
• male
• priority journal

Recent Works

1. Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements

   Journal Article

   Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
   Cancer Discovery (2022)

   Fulltext@MSK | Save
2. Natural history and characteristics of ERBB2-mutated hormone receptor-positive metastatic breast cancer: A multi-institutional retrospective case-control study from AACR Project GENIE

   Journal Article

   LeNoue-Newton, M. L.; Chen, S. C.; Stricker, T.; Hyman, D. M.; Blauvelt, N.; Bedard, P. L.; Meric-Bernstam, F.; Punglia, R. S.; Schrag, D.; Lepisto, E. M.; more...
   Clinical Cancer Research (2022)

   Fulltext@MSK | Save
3. CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization

   Journal Article

   Werr, L.; Plenker, D.; Dammert, M. A.; Lorenz, C.; Brägelmann, J.; Tumbrink, H. L.; Klein, S.; Schmitt, A.; Büttner, R.; Persigehl, T.; more...
   Molecular Cancer Therapeutics (2022)

   Fulltext@MSK | Save